Ivor Royston, CEO & President at Viracta Therapeutics, Inc. (VIRX), sold 13,162 shares at $1.90 ($25K) on 2022-05-26, disclosed to the SEC on 2022-05-27.
Open-market sale of $25k VIRX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VIRX | BUY | 2021-11-15 | $44K | — | Filing → |
| BIOC | BUY | 2017-03-29 | $50K | — | Filing → |
| SNDX | BUY | 2016-03-08 | $1.8M | — | Filing → |